Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies

FDA describes new policies to advance development of safe and effective cell and gene therapies

Source: Food and Drug Administration - January 15, 2019 Category: American Health Source Type: news